Scott has been covering Jim Cramer and Mad Money for The Street since 2006, providing a nightly recap of the show and the Lightning Round as well as maintaining The Street's exclusive Mad Money Stock Screener.
Recent Articles By The Author
Finding Stocks Right for You: Cramer's 'Mad Money' Recap (Friday 8/25/18)
Jim Cramer says it's extremely important to buy stocks that are exactly right for you and your level of risk tolerance.
Roku, GTT Communications, Total SA: 'Mad Money' Lightning Round
Jim Cramer takes a closer look at Roku, GTT Communications, Total SA, Caesars Entertainment, Red Robin Gourmet Burgers, Textainer Group, Camping World and more.
Market Can't Handle the Wild Ride: Cramer's 'Mad Money' Recap (Thursday 5/24/18)
Jim Cramer says this market -- wracked by inflation, tariffs and nuclear tensions -- bounced madly, and it can't value stocks rationally.
Sirius XM Radio, Teva Pharmaceuticals: 'Mad Money' Lightning Round
Jim Cramer weighs in on Sirius XM Radio, Teva Pharmaceuticals, iQIYI, Blue Apron, Shopify, Incyte, E*Trade Financial and more.
Big Turnaround Stories: Cramer's 'Mad Money' Recap (Wednesday 5/23/18)
Jim Cramer tells investors to keep their eyes open for companies making changes -- that's what's being rewarded.
Carnival Corp.: Cramer's Top Takeaways
Arnold Donald, president and CEO of Carnival Corp., tells Jim Cramer how his company uses technology to improve customer service and experience.
First Data, Sprint, T-Mobile US, Altria: 'Mad Money' Lightning Round
Jim Cramer highlights First Data, Sprint, T-Mobile US, Altria, Corning, Beacon Roofing Supply, Verint Systems, Flextronics and more.
Cold Stocks Ready to Heat Up: Cramer's 'Mad Money' Recap (Tuesday 5/22/18)
Jim Cramer says if you really want bigger gains than you can get from riding a hot stock, you have to buy the cold stock of a once-hot company that could flame up.
Royal Caribbean, Allergan, Tyson Foods: 'Mad Money' Lightning Round
Jim Cramer weighs in on Royal Caribbean, Allergan, Tyson Foods, Carrizo Oil & Gas, Valeant Pharmaceuticals, Okta, CRISPR Therapeutics and more.
Ceasefire in Trade War: Cramer's 'Mad Money' Recap (Monday 5/21/18)
Jim Cramer says the hope that the trade dispute with China can be worked out was the fuel for this rally.